Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sunshine Biopharma (SBFM) Cost of Revenue: 2018-2024

Historic Cost of Revenue for Sunshine Biopharma (SBFM) over the last 7 years, with Dec 2024 value amounting to $24.2 million.

  • Sunshine Biopharma's Cost of Revenue rose 13.91% to $6.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.0 million, marking a year-over-year increase of 9.60%. This contributed to the annual value of $24.2 million for FY2024, which is 53.64% up from last year.
  • Sunshine Biopharma's Cost of Revenue amounted to $24.2 million in FY2024, which was up 53.64% from $15.8 million recorded in FY2023.
  • In the past 5 years, Sunshine Biopharma's Cost of Revenue registered a high of $24.2 million during FY2024, and its lowest value of $25,847 during FY2020.
  • For the 3-year period, Sunshine Biopharma's Cost of Revenue averaged around $14.2 million, with its median value being $15.8 million (2023).
  • Data for Sunshine Biopharma's Cost of Revenue shows a peak YoY skyrocketed of 2,148.18% (in 2022) over the last 5 years.
  • Sunshine Biopharma's Cost of Revenue (Yearly) stood at $25,847 in 2020, then surged by 355.87% to $117,830 in 2021, then soared by 2,148.18% to $2.6 million in 2022, then surged by 494.69% to $15.8 million in 2023, then surged by 53.64% to $24.2 million in 2024.